MultiPlan Co. (NYSE:MPLN – Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 302,600 shares, a decline of 13.7% from the November 30th total of 350,700 shares. Approximately 4.6% of the company’s shares are short sold. Based on an average daily trading volume, of 112,900 shares, the days-to-cover ratio is presently 2.7 days.
MultiPlan Price Performance
Shares of MPLN traded down $1.98 during trading hours on Tuesday, hitting $13.48. The stock had a trading volume of 113,710 shares, compared to its average volume of 79,950. The business’s 50 day moving average is $8.30. MultiPlan has a 1-year low of $4.80 and a 1-year high of $58.40. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 21.73. The firm has a market cap of $217.99 million, a price-to-earnings ratio of -0.14 and a beta of 0.42.
Analysts Set New Price Targets
Separately, Citigroup reduced their price objective on shares of MultiPlan from $17.20 to $10.00 and set a “neutral” rating for the company in a research report on Monday, September 23rd.
Institutional Investors Weigh In On MultiPlan
A number of hedge funds have recently added to or reduced their stakes in MPLN. Hsbc Holdings PLC raised its position in shares of MultiPlan by 68.7% during the second quarter. Hsbc Holdings PLC now owns 218,459 shares of the company’s stock worth $87,000 after purchasing an additional 88,944 shares during the period. Fore Capital LLC bought a new position in shares of MultiPlan in the second quarter valued at $37,000. Point72 DIFC Ltd acquired a new position in shares of MultiPlan during the second quarter valued at about $43,000. Cubist Systematic Strategies LLC acquired a new position in shares of MultiPlan during the second quarter valued at about $72,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of MultiPlan during the second quarter worth about $245,000. Institutional investors and hedge funds own 87.15% of the company’s stock.
About MultiPlan
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Recommended Stories
- Five stocks we like better than MultiPlan
- What to Know About Investing in Penny Stocks
- 3 Stocks Helping to Bring AI to Healthcare
- What Are Dividend Challengers?
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- How Can Investors Benefit From After-Hours Trading
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Receive News & Ratings for MultiPlan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MultiPlan and related companies with MarketBeat.com's FREE daily email newsletter.